Cancer
CT83/KKLC1 Peptide Pool, human
€237.50*
Prices excl. VAT plus shipping
costs
Available, delivery time:
1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Caution:
For research use only. Not for use in humans.
1
Product number: LB01673
Description
Pool of 26 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Kita-kyushu lung cancer antigen 1 (UniProtID: Q5H943) of Homo sapiens (Human) for T cell assays (e.g. ELISPOT).
One unit allows the stimulation of 2,5 x 108 cells.
You can find applications and references in our blog post: Esophagogastric adenocarcinoma: Tumor-associated antigens, immune responses and HLA-I Expression
TechData
| Gene: | CT83 |
| Delivery: | 1-3 days |
| Counterion: | TFA |
| Length: | 113 amino acids |
| No. Peptides: | 26 peptides |
| Amount/Aliquote: | 15 nmol (approx. 25µg)/peptide for stimulation of 2,5 x 108 cells |
| Solubility: | Dissolve in a minimum amount of pure DMSO (40µl) and dilute with water to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system. |
| Protein: | Kita-kyushu lung cancer antigen 1 |
| UniProt Id: | Q5H943 |
| Species: | Human |
| Application: | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
| Indication: | Cancer |
Documents
References
Thelen M, Keller D, Lehmann J, et al.: Immune responses against shared antigens are common in esophago-gastric cancer and can be enhanced using CD40-activated B cells. Journal for ImmunoTherapy of Cancer 2022;10:e005200. doi: 10.1136/jitc-2022-005200